These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 28296566)
1. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro. Qi J; Wang R; Zeng Y; Yu W; Gu Y Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566 [TBL] [Abstract][Full Text] [Related]
2. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity. Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142 [TBL] [Abstract][Full Text] [Related]
3. Antibodies and activity measurements for the detection of O-GlcNAc transferase and assay of its substrate, UDP-GlcNAc. Lefebvre T; Drougat L; Olivier-Van Stichelen S; Michalski JC; Vercoutter-Edouart AS Methods Mol Biol; 2013; 1022():147-59. PubMed ID: 23765660 [TBL] [Abstract][Full Text] [Related]
4. Functional analysis of recombinant human and Yarrowia lipolytica O-GlcNAc transferases expressed in Saccharomyces cerevisiae. Oh HJ; Moon HY; Cheon SA; Hahn Y; Kang HA J Microbiol; 2016 Oct; 54(10):667-74. PubMed ID: 27687229 [TBL] [Abstract][Full Text] [Related]
5. O-GlcNAc transferase inhibitors: current tools and future challenges. Trapannone R; Rafie K; van Aalten DM Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193 [TBL] [Abstract][Full Text] [Related]
7. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins. Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592 [TBL] [Abstract][Full Text] [Related]
8. The conserved threonine-rich region of the HCF-1 Kapuria V; Röhrig UF; Waridel P; Lammers F; Borodkin VS; van Aalten DMF; Zoete V; Herr W J Biol Chem; 2018 Nov; 293(46):17754-17768. PubMed ID: 30224358 [No Abstract] [Full Text] [Related]
9. Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe. Kositzke A; Fan D; Wang A; Li H; Worth M; Jiang J Int J Biol Macromol; 2021 Feb; 169():51-59. PubMed ID: 33333092 [TBL] [Abstract][Full Text] [Related]
10. OGT: a short overview of an enzyme standing out from usual glycosyltransferases. Aquino-Gil M; Pierce A; Perez-Cervera Y; Zenteno E; Lefebvre T Biochem Soc Trans; 2017 Apr; 45(2):365-370. PubMed ID: 28408476 [No Abstract] [Full Text] [Related]
11. Overview of the Assays to Probe Balsollier C; Pieters RJ; Anderluh M Molecules; 2021 Feb; 26(4):. PubMed ID: 33669256 [No Abstract] [Full Text] [Related]
12. Catalytic Promiscuity of O-GlcNAc Transferase Enables Unexpected Metabolic Engineering of Cytoplasmic Proteins with 2-Azido-2-deoxy-glucose. Shen DL; Liu TW; Zandberg W; Clark T; Eskandari R; Alteen MG; Tan HY; Zhu Y; Cecioni S; Vocadlo D ACS Chem Biol; 2017 Jan; 12(1):206-213. PubMed ID: 27935279 [TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc modification affects the ATM-mediated DNA damage response. Miura Y; Sakurai Y; Endo T Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405 [TBL] [Abstract][Full Text] [Related]
14. Substrate specificity provides insights into the sugar donor recognition mechanism of O-GlcNAc transferase (OGT). Ma X; Liu P; Yan H; Sun H; Liu X; Zhou F; Li L; Chen Y; Muthana MM; Chen X; Wang PG; Zhang L PLoS One; 2013; 8(5):e63452. PubMed ID: 23700425 [TBL] [Abstract][Full Text] [Related]
15. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis. Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569 [TBL] [Abstract][Full Text] [Related]
16. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling. Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217 [TBL] [Abstract][Full Text] [Related]
17. Cross regulation between mTOR signaling and O-GlcNAcylation. Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020 [TBL] [Abstract][Full Text] [Related]
18. Substrate and product analogues as human O-GlcNAc transferase inhibitors. Dorfmueller HC; Borodkin VS; Blair DE; Pathak S; Navratilova I; van Aalten DM Amino Acids; 2011 Mar; 40(3):781-92. PubMed ID: 20640461 [TBL] [Abstract][Full Text] [Related]
19. A highly effective and adjustable dual plasmid system for O-GlcNAcylated recombinant protein production in E. coli. Han C; Shan H; Bi C; Zhang X; Qi J; Zhang B; Gu Y; Yu W J Biochem; 2015 Jun; 157(6):477-84. PubMed ID: 25619971 [TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcylation regulates β1,4-GlcNAc-branched N-glycan biosynthesis via the OGT/SLC35A3/GnT-IV axis. Song W; Isaji T; Nakano M; Liang C; Fukuda T; Gu J FASEB J; 2022 Feb; 36(2):e22149. PubMed ID: 34981577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]